Fourth quarter 2024 total revenue of approximately $57.6 million, which includes TAVALISSE® net product sales of $31.0 million, REZLIDHIA® net product sales of $7.4 ...

Request To Download Free Sample of This Strategic Report @- https://reportocean.com/industry-verticals/sample-request?report_id=Pol1398 ...

Grifols revenue and EBITDA growth, improved leverage ratio, and significant liquidity highlight its resilience and potential ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

Grifols reported a 13.6% increase in Q4 revenues year-on-year. The company's leverage ratio improved, decreasing from 6.8x in Q1 to 4.6x by year-end. Innovation milestones for 2024 were ...

BARCELONA (Reuters) - Spanish drugmaker Grifols (GRFS) reported on Wednesday a net profit of 157 million euros ($165.02 million) for 2024 on revenues of 7.21 billion euros, up 10.2% from a year ...

Reports Q4 revenue of EUR 1.976B, up 13.6% at constant currency. Nacho Abia, Chief Executive Officer, commented, “Grifols (GRFS) delivered an all-time high performance, achieving its 2024 ...

Improvements in medical technology, medications, and therapeutic approaches have changed the course of patient care. As the need for quick results has grown, pharmaceutical corporations in ...

For exclusive news and updates, subscribe to our Chicago Med Newsletter: Frost’s (Darren Barnet) past is coming back to haunt him as Chicago Med Season 10 continues. “His time as a child star ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A medical loan is an unsecured personal loan that covers health care costs. It can be used to cover emergency or planned medical procedures, consolidate existing medical debt, or pay for high ...

Jorg Schuttrmpf, Chief Scientific Innovation Officer at Grifols, said in a recent interview with medical journal Drug Target Review, "Plasma, the liquid component of blood, holds vital clues about ...